Berlin, 08.06.2000. Eckert & Ziegler Strahlen- und Medizintechnik, Berlin, a leading provider of low-level radioactive components for industrial and medical applications, has increased its capital by 250,000 new shares to a total of 3,250,000 shares. The price for the new shares has been set to 70.5 Euro per share, with a rights ratio of 12:1. The rights will be traded from 13 to 26 of June (date included), and the new shares will be available from 30 June on.
The revenues from the secondary offering will be used by Eckert & Ziegler for the acquisition of the worldwide Sources Business from DuPont Pharmaceuticals Company, Delaware (USA) and for the improvement of its capital ratio.
The Board of Directors